Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 527

1.

New generation smallpox vaccines: a review of preclinical and clinical data.

Artenstein AW.

Rev Med Virol. 2008 Jul-Aug;18(4):217-31. doi: 10.1002/rmv.571. Review.

PMID:
18283712
[PubMed - indexed for MEDLINE]
2.

Smallpox vaccines for biodefense: need and feasibility.

Artenstein AW, Grabenstein JD.

Expert Rev Vaccines. 2008 Oct;7(8):1225-37. doi: 10.1586/14760584.7.8.1225. Review.

PMID:
18844596
[PubMed - indexed for MEDLINE]
3.

Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.

Meseda CA, Garcia AD, Kumar A, Mayer AE, Manischewitz J, King LR, Golding H, Merchlinsky M, Weir JP.

Virology. 2005 Sep 1;339(2):164-75.

PMID:
15993917
[PubMed - indexed for MEDLINE]
Free Article
4.

The new ACAM2000 vaccine and other therapies to control orthopoxvirus outbreaks and bioterror attacks.

Handley L, Buller RM, Frey SE, Bellone C, Parker S.

Expert Rev Vaccines. 2009 Jul;8(7):841-50. doi: 10.1586/erv.09.55. Review.

PMID:
19538111
[PubMed - indexed for MEDLINE]
5.

LC16m8: an attenuated smallpox vaccine.

Kenner J, Cameron F, Empig C, Jobes DV, Gurwith M.

Vaccine. 2006 Nov 17;24(47-48):7009-22. Epub 2006 Apr 21. Review.

PMID:
17052815
[PubMed - indexed for MEDLINE]
6.

Smallpox vaccines: Past, present, and future.

Parrino J, Graham BS.

J Allergy Clin Immunol. 2006 Dec;118(6):1320-6. Review.

PMID:
17157663
[PubMed - indexed for MEDLINE]
7.

The nonreplicating smallpox candidate vaccines defective vaccinia Lister (dVV-L) and modified vaccinia Ankara (MVA) elicit robust long-term protection.

Coulibaly S, Brühl P, Mayrhofer J, Schmid K, Gerencer M, Falkner FG.

Virology. 2005 Oct 10;341(1):91-101.

PMID:
16061267
[PubMed - indexed for MEDLINE]
Free Article
8.

Third-generation smallpox vaccines: challenges in the absence of clinical smallpox.

Meseda CA, Weir JP.

Future Microbiol. 2010 Sep;5(9):1367-82. doi: 10.2217/fmb.10.98. Review.

PMID:
20860482
[PubMed - indexed for MEDLINE]
9.

Smallpox vaccine: problems and prospects.

Poland GA, Neff JM.

Immunol Allergy Clin North Am. 2003 Nov;23(4):731-43. Review.

PMID:
14753389
[PubMed - indexed for MEDLINE]
10.

ACAM2000: a newly licensed cell culture-based live vaccinia smallpox vaccine.

Greenberg RN, Kennedy JS.

Expert Opin Investig Drugs. 2008 Apr;17(4):555-64. doi: 10.1517/13543784.17.4.555 . Review.

PMID:
18363519
[PubMed - indexed for MEDLINE]
11.

IMVAMUNE: modified vaccinia Ankara strain as an attenuated smallpox vaccine.

Kennedy JS, Greenberg RN.

Expert Rev Vaccines. 2009 Jan;8(1):13-24. doi: 10.1586/14760584.8.1.13. Review.

PMID:
19093767
[PubMed - indexed for MEDLINE]
12.

Modified vaccinia Ankara: potential as an alternative smallpox vaccine.

McCurdy LH, Larkin BD, Martin JE, Graham BS.

Clin Infect Dis. 2004 Jun 15;38(12):1749-53. Epub 2004 May 19.

PMID:
15227622
[PubMed - indexed for MEDLINE]
Free Article
13.

IMVAMUNE, an attenuated modified vaccinia Ankara virus vaccine for smallpox infection.

Jones T.

Curr Opin Mol Ther. 2008 Aug;10(4):407-17.

PMID:
18683106
[PubMed - indexed for MEDLINE]
14.

Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine.

Vollmar J, Arndtz N, Eckl KM, Thomsen T, Petzold B, Mateo L, Schlereth B, Handley A, King L, Hülsemann V, Tzatzaris M, Merkl K, Wulff N, Chaplin P.

Vaccine. 2006 Mar 15;24(12):2065-70. Epub 2005 Nov 28.

PMID:
16337719
[PubMed - indexed for MEDLINE]
15.

Vaccines for preventing smallpox.

Metzger W, Mordmueller BG.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD004913. Review.

PMID:
17636779
[PubMed - indexed for MEDLINE]
16.

ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain)--a second-generation smallpox vaccine for biological defense.

Monath TP, Caldwell JR, Mundt W, Fusco J, Johnson CS, Buller M, Liu J, Gardner B, Downing G, Blum PS, Kemp T, Nichols R, Weltzin R.

Int J Infect Dis. 2004 Oct;8 Suppl 2:S31-44. Review.

PMID:
15491873
[PubMed - indexed for MEDLINE]
Free Article
17.

Clonal vaccinia virus grown in cell culture as a new smallpox vaccine.

Weltzin R, Liu J, Pugachev KV, Myers GA, Coughlin B, Blum PS, Nichols R, Johnson C, Cruz J, Kennedy JS, Ennis FA, Monath TP.

Nat Med. 2003 Sep;9(9):1125-30. Epub 2003 Aug 17.

PMID:
12925845
[PubMed - indexed for MEDLINE]
18.

Mouse neurotoxicity test for vaccinia-based smallpox vaccines.

Li Z, Rubin SA, Taffs RE, Merchlinsky M, Ye Z, Carbone KM.

Vaccine. 2004 Mar 29;22(11-12):1486-93.

PMID:
15063573
[PubMed - indexed for MEDLINE]
19.

Safety, immunogenicity and protective efficacy in mice of a new cell-cultured Lister smallpox vaccine candidate.

Ferrier-Rembert A, Drillien R, Meignier B, Garin D, Crance JM.

Vaccine. 2007 Nov 28;25(49):8290-7. Epub 2007 Oct 11.

PMID:
17964011
[PubMed - indexed for MEDLINE]
20.

An update on smallpox vaccine candidates and their role in bioterrorism related vaccination strategies.

Wiser I, Balicer RD, Cohen D.

Vaccine. 2007 Jan 22;25(6):976-84. Epub 2006 Sep 22. Review.

PMID:
17074424
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk